|
1 Introduction: How We Encountered TCTP and Our Purpose in Studying It |
|
|
1 | (8) |
|
|
|
1.1 The Initial Years: The Tumor Reversion Project |
|
|
2 | (1) |
|
1.2 Learning to Work with High-Throughput Technology and the First Molecular Data |
|
|
3 | (1) |
|
1.3 The Year 2000: Giving a Decisive Turn into the Understanding of the Tumor Reversion Program |
|
|
3 | (1) |
|
1.4 The P53-TCTP Reciprocal Negative Feedback Loop and the Clinical Significance |
|
|
4 | (1) |
|
1.5 Conclusion and Perspectives |
|
|
5 | (4) |
|
|
6 | (3) |
|
2 Structural Insights into TCTP and Its Interactions with Ligands and Proteins |
|
|
9 | (38) |
|
|
|
|
|
9 | (1) |
|
2.2 Sequence and Structure of TCTP |
|
|
10 | (11) |
|
2.2.1 Description of the Structure of TCTP |
|
|
10 | (2) |
|
2.2.2 Structural Homologues of TCTP |
|
|
12 | (5) |
|
2.2.3 Functional Elements Within TCTP Sequence |
|
|
17 | (4) |
|
2.3 Binding Properties and Structural Aspects of TCTP in Complex with Ions, Small Molecules, Carbohydrates, Peptides, and Nucleic Acids |
|
|
21 | (8) |
|
|
21 | (2) |
|
2.3.2 Antihistaminic Drugs and the Related Sertraline/Thioridazine |
|
|
23 | (3) |
|
|
26 | (1) |
|
2.3.4 Heme, Artemisinine, and Analogs |
|
|
26 | (1) |
|
|
27 | (1) |
|
2.3.6 Bombyx mori TCTP as a Binding Platform for Saccharides |
|
|
28 | (1) |
|
2.4 Structural Aspects of TCTP in Complex with Proteins |
|
|
29 | (9) |
|
2.4.1 TCTP Directly Interacts with Dozens of Proteins |
|
|
29 | (6) |
|
2.4.2 Structural Information on Native Complexes |
|
|
35 | (3) |
|
2.4.3 TCTP Tends to Self-associate |
|
|
38 | (1) |
|
|
38 | (9) |
|
|
40 | (7) |
|
3 Structure-Function Relationship of TCTP |
|
|
47 | (22) |
|
Beatriz Xoconostle-Cazares |
|
|
|
|
48 | (1) |
|
3.2 Conserved Functions of TCTP Across Kingdoms |
|
|
49 | (1) |
|
3.3 Taxon-Specific Functions of TCTP |
|
|
50 | (10) |
|
|
51 | (1) |
|
|
52 | (3) |
|
3.3.3 Blood-Borne and Other Vertebrate Parasites |
|
|
55 | (5) |
|
3.4 Non-cell Autonomous Functions of TCTP |
|
|
60 | (3) |
|
|
63 | (6) |
|
|
64 | (5) |
|
4 The Translational Controlled Tumour Protein TCTP: Biological Functions and Regulation |
|
|
69 | (58) |
|
|
|
70 | (5) |
|
4.1.1 The `Translationally Controlled Tumour Protein TCTP': Names and History |
|
|
71 | (1) |
|
4.1.2 Gene Structure and mRNA |
|
|
72 | (2) |
|
4.1.3 Molecular Structure, Conservation and Interactions |
|
|
74 | (1) |
|
4.2 Biological Functions of TCTP |
|
|
75 | (16) |
|
4.2.1 Maintaining Cell Homoeostasis and Survival |
|
|
75 | (6) |
|
4.2.2 Involvement in the Cell Cycle and in Early Development |
|
|
81 | (4) |
|
4.2.3 TCTP in Cell Growth Regulation, Protein Synthesis and Degradation |
|
|
85 | (3) |
|
4.2.4 Extracellular Functions of TCTP |
|
|
88 | (3) |
|
4.3 Involvement of TCTP in Disease Processes |
|
|
91 | (14) |
|
4.3.1 TCTP in Human Cancer |
|
|
91 | (7) |
|
4.3.2 Participation in Immunological Reactions |
|
|
98 | (2) |
|
4.3.3 TCTP in Lower Animals and Parasitic Infections |
|
|
100 | (3) |
|
4.3.4 TCTP in Other (Patho)physiological Processes |
|
|
103 | (2) |
|
4.4 Regulation of Cellular TCTP Levels |
|
|
105 | (7) |
|
4.4.1 Cell Physiologic Conditions That Result in Regulation of TCTP Levels |
|
|
105 | (1) |
|
4.4.2 Mechanisms Involved in Regulation of Cellular TCTP Levels |
|
|
105 | (7) |
|
|
112 | (15) |
|
|
114 | (13) |
|
5 Current Understanding of the TCTP Interactome |
|
|
127 | (10) |
|
|
|
|
127 | (1) |
|
5.2 Global Interactome Profiling Methods |
|
|
128 | (1) |
|
5.3 The Current Knowledge of the TCTP Interactome |
|
|
129 | (4) |
|
|
130 | (1) |
|
5.3.2 Nucleic Acid-Binding Proteins |
|
|
130 | (1) |
|
5.3.3 Cytoskeletal Proteins |
|
|
130 | (2) |
|
|
132 | (1) |
|
|
133 | (4) |
|
|
133 | (4) |
|
6 Role and Fate of TCTP in Protein Degradative Pathways |
|
|
137 | (12) |
|
|
|
138 | (1) |
|
6.2 TCTP as Protein Stabilizer |
|
|
138 | (3) |
|
6.2.1 TCTP Masks the Ubiquitination Sites of Its Partners |
|
|
139 | (1) |
|
6.2.2 TCTP Binding Leads to E3 Ligase Degradation |
|
|
140 | (1) |
|
6.2.3 Mmi1/ScTCTP Modulates Proteasome Activity |
|
|
140 | (1) |
|
6.3 TCTP as Degradation Inducer |
|
|
141 | (1) |
|
|
142 | (2) |
|
|
144 | (5) |
|
|
146 | (3) |
|
7 Roles of the Translationally Controlled Tumor Protein (TCTP) in Plant Development |
|
|
149 | (24) |
|
|
|
|
|
|
149 | (1) |
|
7.2 Features of Plant TCTP Genes |
|
|
150 | (4) |
|
7.3 TCTP Is Essential for Plant Development |
|
|
154 | (4) |
|
7.4 Role of TCTP in Plant Signaling |
|
|
158 | (8) |
|
7.4.1 Is TCTP a Component of the TOR Pathway? |
|
|
158 | (2) |
|
7.4.2 Role of TCTP in Hormone Signaling |
|
|
160 | (2) |
|
7.4.3 Response to Abiotic and Biotic Stresses |
|
|
162 | (4) |
|
|
166 | (7) |
|
|
166 | (7) |
|
8 Function of Translationally Controlled Tumor Protein in Organ Growth: Lessons from Drosophila Studies |
|
|
173 | (20) |
|
|
|
|
|
173 | (1) |
|
8.2 Identification of Drosophila Tctp Function in Organ Growth |
|
|
174 | (1) |
|
8.3 Role of Tctp in TOR Signaling |
|
|
175 | (3) |
|
8.4 Regulation of Tctp Function by 14-3-3 |
|
|
178 | (3) |
|
8.5 Effects of 14-3-3 Isoforms and Tctp on Cyclin E |
|
|
181 | (1) |
|
8.6 Tctp Function in DNA Damage Control |
|
|
181 | (3) |
|
8.7 Tctp in Chromatin Remodeling and Genome Stability |
|
|
184 | (1) |
|
|
185 | (8) |
|
|
187 | (6) |
|
9 Translationally Controlled Tumor Protein (TCTP/HRF) in Animal Venoms |
|
|
193 | (8) |
|
|
|
193 | (1) |
|
9.2 Loxosceles intermedia TCTP |
|
|
194 | (2) |
|
9.3 Other TCTPs Found in Animal Venoms |
|
|
196 | (2) |
|
|
198 | (3) |
|
|
199 | (2) |
|
10 Tctp in Neuronal Circuitry Assembly |
|
|
201 | (16) |
|
|
|
|
202 | (5) |
|
10.1.1 Features of Axon Development |
|
|
202 | (1) |
|
10.1.2 Axonal mRNA Localization: One in Thousands |
|
|
202 | (3) |
|
10.1.3 Axon Guidance and Cancer: Shared Features |
|
|
205 | (2) |
|
10.1.4 Axonal Mitochondria |
|
|
207 | (1) |
|
10.2 TCTP in Neuronal Circuitry Assembly |
|
|
207 | (5) |
|
10.3 Summary and Future Directions |
|
|
212 | (5) |
|
|
213 | (4) |
|
11 Elusive Role of TCTP Protein and mRNA in Cell Cycle and Cytoskeleton Regulation |
|
|
217 | (10) |
|
|
|
|
218 | (3) |
|
11.1.1 The Role of TCTP Protein |
|
|
218 | (2) |
|
11.1.2 The Role of TCTP mRNA |
|
|
220 | (1) |
|
11.2 TCTP and Cytoskeleton |
|
|
221 | (2) |
|
11.2.1 TCTP and Microtubules |
|
|
222 | (1) |
|
|
223 | (1) |
|
|
223 | (4) |
|
|
223 | (4) |
|
12 The Translationally Controlled Tumor Protein and the Cellular Response to Ionizing Radiation-Induced DNA Damage |
|
|
227 | (28) |
|
|
|
|
|
|
228 | (2) |
|
12.2 Primary Effects of Ionizing Radiation |
|
|
230 | (2) |
|
12.2.1 Direct and Indirect Effects of Ionizing Radiation |
|
|
230 | (2) |
|
12.3 Endogenous and Radiation-Induced DNA Alterations |
|
|
232 | (5) |
|
12.3.1 DNA Damage Response Pathways and DNA Damage Repair Mechanisms |
|
|
233 | (4) |
|
12.4 TCTP and the Sensing of Genotoxic Stress |
|
|
237 | (3) |
|
12.5 TCTP and the Repair of DNA Damage |
|
|
240 | (2) |
|
12.6 TCTP and Control of Cell Cycle Progression Under Normal and Stress Conditions |
|
|
242 | (2) |
|
|
244 | (1) |
|
|
245 | (10) |
|
|
247 | (8) |
|
13 TCTP Has a Crucial Role in the Different Stages of Prostate Cancer Malignant Progression |
|
|
255 | (8) |
|
|
|
|
13.1 TCTP Is Upregulated in Prostate Cancer |
|
|
256 | (1) |
|
13.2 TCTP: A Promising Target in Castration-Resistant Prostate Cancer |
|
|
256 | (4) |
|
13.2.1 TCTP Mediates Heat Shock Protein 27 Cytoprotective Function in CRPC |
|
|
256 | (1) |
|
13.2.2 TCTP and P53 in CRPC: "Neither Can Live While the Other Survives" |
|
|
257 | (2) |
|
13.2.3 Development of a TCTP Antisense Oligonucleotide for Clinical Applications |
|
|
259 | (1) |
|
|
260 | (3) |
|
|
260 | (3) |
|
14 Role of TCTP for Cellular Differentiation and Cancer Therapy |
|
|
263 | (20) |
|
|
|
|
|
265 | (3) |
|
14.1.1 TCTP in Differentiation Processes |
|
|
266 | (2) |
|
|
268 | (3) |
|
14.2.1 TCTP and Tumor Reversion |
|
|
268 | (1) |
|
14.2.2 TCTP as Antiapoptotic Protein |
|
|
269 | (1) |
|
14.2.3 Cell Cycle Regulation of TCTP |
|
|
270 | (1) |
|
14.2.4 TCTP Reduces Cellular Stress |
|
|
271 | (1) |
|
14.3 TCTP for Differentiation Therapy |
|
|
271 | (4) |
|
14.3.1 Approaches of Differentiation Therapy in General |
|
|
271 | (1) |
|
|
272 | (1) |
|
14.3.3 Histone Deacetylase Inhibitors |
|
|
272 | (1) |
|
|
273 | (1) |
|
|
273 | (1) |
|
14.3.6 Differentiation Therapy with Antihistaminic Drugs |
|
|
274 | (1) |
|
14.4 Conclusions and Perspectives |
|
|
275 | (8) |
|
|
276 | (7) |
|
15 Targeting TCTP with Sertraline and Thioridazine in Cancer Treatment |
|
|
283 | (8) |
|
|
|
|
|
|
|
283 | (1) |
|
15.2 Experimental Approach |
|
|
284 | (4) |
|
15.3 Conclusion and Therapeutic Perspectives |
|
|
288 | (3) |
|
|
289 | (2) |
|
16 History of Histamine-Releasing Factor (HRF)/Translationally Controlled Tumor Protein (TCTP) Including a Potential Therapeutic Target in Asthma and Allergy |
|
|
291 | (18) |
|
|
16.1 Introduction/Cloning |
|
|
292 | (1) |
|
16.2 Clinical Relevance of HRF/TCTP |
|
|
293 | (1) |
|
16.3 HRF/TCTP Extracellular Functions |
|
|
294 | (1) |
|
16.4 Other Functions of HRF/TCTP (Mainly Intracellular) |
|
|
295 | (1) |
|
16.5 An Inducible HRF/TCTP Transgenic Mouse |
|
|
296 | (2) |
|
16.6 The Importance of Ship-1 on HRF/TCTP Signaling |
|
|
298 | (2) |
|
16.7 Additional Intracellular Signaling by HRF/TCTP |
|
|
300 | (1) |
|
16.8 HRF/TCTP as a Therapeutic Target |
|
|
301 | (2) |
|
|
303 | (6) |
|
|
304 | (5) |
Conclusion |
|
309 | |